Psoriasis: latest news - GoINPHARMA
Wednesday, 24 April 2019 - 23:22


Bausch Health announces good Phase III results from psoriasis therapy

Bausch Health–formerly known as Valeant–yesterday reported on a press release that the Journal of Drugs in Dermatology has published results from as many as two Phase III clinical trials, assessing corticosteroid Bryhali (halobetasol propionate) Lotion, 0.01% in patients with psoriasis….

Psoriasis: positive opinion in Europe on Almirall’s Skilarence

EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending a marketing authorization for Almirall’s Skilarence, for the treatment of psoriasis. The product will be available as 30-mg and 120-mg gastro-resistant tablets. Its active ingredient…